WALFS Pharma
WALFS Pharma
  • Home
  • Products
    • Products Overview
    • Anti-Diabetic
    • Antibiotics/Anti-cold
    • Gastroenteric
    • Neuro
    • Pain Management
    • Urology
    • Venous
    • Wound Care
  • Operations
  • About Us
    • About WALFS
    • Core Values
    • Leadership
    • Healthcare Advisors
    • Partners
  • Blog
  • Careers
  • Contact Us
  • More
    • Home
    • Products
      • Products Overview
      • Anti-Diabetic
      • Antibiotics/Anti-cold
      • Gastroenteric
      • Neuro
      • Pain Management
      • Urology
      • Venous
      • Wound Care
    • Operations
    • About Us
      • About WALFS
      • Core Values
      • Leadership
      • Healthcare Advisors
      • Partners
    • Blog
    • Careers
    • Contact Us
  • Home
  • Products
    • Products Overview
    • Anti-Diabetic
    • Antibiotics/Anti-cold
    • Gastroenteric
    • Neuro
    • Pain Management
    • Urology
    • Venous
    • Wound Care
  • Operations
  • About Us
    • About WALFS
    • Core Values
    • Leadership
    • Healthcare Advisors
    • Partners
  • Blog
  • Careers
  • Contact Us
THERAPEUTIC AREA

Anti-Diabetic

Time-tested Medications for Managing Blood Sugar Levels

OVERVIEW

Diabetes is a chronic condition characterized by high blood glucose levels, which can lead to various complications if not properly managed. Effective care for diabetes is essential to maintain optimal blood sugar control, prevent complications, and improve overall well-being for individuals living with the condition. We are committed to the fight against diabetes and offer products that focus on better long-term management of this chronic disease.

1-2022-Visual-Aid-AntiDiabetic (pdf)

Download

Glimwalf M1 and M2

FOR LONGER ACTION IN DIABETES


Metformin Hydrochloride 500 mg (SR) with  Glimepiride 1 & 2 mg Tablets


METMORFIN:

  • Decreases HbA1c by 1.2 to 1.9% in Patients with T2DM.
  • It doesn’t produce Hypoglycemia in normal subjects.


GLIMEPIRIDE:

  • An Antidiabetic with least risk of Hypoglycaemia.
  • Increase Peripheral Glucose utilization by 29% .
  • Controls Blood Glucose Without Deleterious changes.
  • Enhanced efficiency compared to other combinations.


INDICATIONS:

Type 2 DM Patients who do not respond to Mono therapy.

Vildawalf M

THE IDEAL GLIPTIN TO SURPASS DIABETES CONTROL


An adjunct to diet and exercise to improve glycemic control in patients with Type 2 Diabetes Mellitus.


Vildagliptin 50 mg & Metformin 500 mg Tablets


  • A potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor that improves glycemic control
  • Vildagliptin add on therapy in patients with Metformin
  • Enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion
  • Well tolerated and efficacious in improving glycemic control in patients with type 2 diabetes mellitus (T2DM)

DAPAWALF-10

TO TREAT TYPE 2 DIABETES


To improve glycemic control in patients with Type 2 Diabetes Mellitus.


Dapagliflozin 10 mg Tablets


  • For patients with type 2 diabetes who cannot take metmorfin.
  • For heart failure – it can reduce the risk of the heart getting weaker, and help symptoms such as tiredness
  • For chronic kidney disease – it helps to slow the rate at which the condition gets worse
  • Dapagliflozin works on your kidneys. It increases the amount of sugar removed from your body when you urinate. It can also reduce the amount of work your heart needs to do to pump blood around the body.
  • May take up to a week for it to take full effect.
  • Dapagliflozin does not make you put on weight. In fact, some people find they lose weight.

  • Home
  • Products Overview
  • Operations
  • About WALFS
  • Blog
  • Careers
  • Contact Us

WALFS Pharma Private Limited

Registered Office: No. 78, Perambur High Road, Perambur, Chennai 600 011, Tamilnadu, India | Corporate Office: Navins Presidium, Tower B, 2nd floor, 103 A, Nelson Manickam Road, Aminjikarai, Chennai - 600 029, Tamilnadu, India..

+91 44 48572239 sales@walfspharma.com

Copyright © 2023 WALFS Pharma. All Rights Reserved. Terms of Use   |  Privacy Policy  |  Disclaimer

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept